logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PPP-9. Composition of illicit drug tablets, 2009 [see all tables in this series...]

Part (iv) Information available on substances listed in categories 'Miscellaneous' and 'Other'

CountryInformation available on substances listed in categories "Miscellaneous" and "Other"
BelgiumTablets containing mCPP are included in the category "miscellaneous". In 2009 most "miscellaneous" records contained mCPP (alone or in combination with other substance)
BulgariaIn category "miscellaneous" most of the cases concerned forms of CPP, barbiturates and benzodiazepine derivates. Category "others" includes tablets containing 2C-B and GHB.
Czech Republic:
DenmarkTablets in the category "other" are mainly mCPP, alone or in combination with other substances. The 77% breakdown as follow: 17% mCPP; 2% mCPP + MDMA; 48% mCPP + amphetamine; 7% 2C-B; 1% 2C-I ; 1% PCP + methamphetamine. Tablets in the category "miscellaneous" are caffeine and/or ephedrine.
GermanyTablets included in the category "others" only contain mCPP.
EstoniaTablets included in the category "others" only contain 4-CPP.
Ireland:
GreeceNo information is available due that neither categories, "miscellaneous" nor "others", represent more than 5% of the records.
SpainThe category "miscellaneous" includes mainly benzodiazepines, ketamine and DOB.
France-ATablets containing mCPP - 4-fluoroamphetamine are included in the category "miscellaneous".
France-BTablets containing mCPP are included in the category "miscellaneous".
ItalyCategory "Miscellaneous" includes mainly mCPP ( 96%). Category "Other" refers to LSD stamps.
CyprusTablets in the category "others" (71.7%) breakdown as follow: 87.9% BZP+TMPP+DBZP and 5.6% mCPP and "miscellaneous": 6.5% methandrostenolone.
LatviaNo information available.
Lithuania:
LuxembourgTablets in the category "other / miscellaneous" are mainly caffeine, paracetamol and ibuprofen.
HungaryTablets in the category "others" (11.6%) breakdown as follow: 8.68% BZP, 1.65% GHB and 1.24% 2C-B . The 33.5 % into the category "miscellaneous" breakdown as follow: 28.10% mCPP, 3.31% MDPV, 1.24% 4-FA , 0.41% butylone and 0.41% ketamine+mCPP.
Malta:
NetherlandsTablets in the category "miscellaneous" are mainly mCPP (12%) and mephedrone (7%).
AustriaTablets containing mCPP are included in the category "miscellaneous". In 2009 the 3.51% in the category "others" breakdown as follow: PMA n=3; methcathinone n=1 and the 76.32% in the category "miscellaneous" breakdown as follow: mCPP+metoclopramide n=15; mCPP+unknown substance(s) n=11; mCPP n=31; fenproporex n=1; unknown substance(s) n=28; unknown substance +TFMPP n=1.
PolandNo information available.
PortugalTablets in the category "miscellaneous" (95.81%) breakdowns as follow: 5 records of BZP (70.98 %), 33 records of mCPP (4%), 5 records of 2C-B (0.55%) and 1 record of Piperonal (24.38%); BZP= 17051 tablets, mCPP= 983 tablets, 2C-B= 131 tablets and Piperonal= 5856 tablets.
Romania:
Slovenia-A:
Slovenia-B:
SlovakiaTablets included in the category "miscellaneous" only contain mCPP.
FinlandTablets included in the category "miscellaneous" contain mainly mCPP and TFMPP+BZP.
Sweden:
United KingdomTablets in the category "miscellaneous" are piperazine type tablets (BZP, TFMPP and CPP).
CroatiaTablets in the category "miscellaneous" are mCPP alone and in combination with traces of MDMA, amphetamine, TFMPP or parafluoroamphetamine and in the category "others" are 2C-B, 4-bromo-2,5-dimethoxyphenethylamine and controlled substance in combination with mCPP.
TurkeyTablets included in the category "miscellaneous" contain: MDMA+mCPP, MDMA+mCPP+caffeine, benzodiazepines (clonazepam and alprazolam) and biperidene.
NorwayNo information available.

(see the help page for information about formats etc.)

Page last updated: Wednesday, 22 June 2011